13 results on '"Janouskova O"'
Search Results
2. Light-Activated Carbon Monoxide Prodrugs Based on Bipyridyl Dicarbonyl Ruthenium(II) Complexes
- Author
-
Geri, S., Krunclova, T., Janouskova, O., Panek, J., Hruby, M., Hernandez-Valdes, D., Probst, B., Alberto, R., (0000-0003-1906-3186) Mamat, C., (0000-0001-8857-5922) Kubeil, M., (0000-0002-2972-2803) Stephan, H., Geri, S., Krunclova, T., Janouskova, O., Panek, J., Hruby, M., Hernandez-Valdes, D., Probst, B., Alberto, R., (0000-0003-1906-3186) Mamat, C., (0000-0001-8857-5922) Kubeil, M., and (0000-0002-2972-2803) Stephan, H.
- Abstract
Two photoactivatable dicarbonyl ruthenium(II) complexes based on an amide-functionalised bipyridine scaffold (4-position) equipped with an alkyne functionality or a green-fluorescent BODIPY (boron-dipyrromethene) dye have been prepared and used to investigate their light-induced decarbonylation. UV/Vis, FT-IR and 13C NMR spectroscopies as well as gas chromatography and multivariate curve resolution alternating least-squares analysis (MCR-ALS) were used to elucidate the mechanism of the decarbonylation process. Release of the first CO molecule occurs very quickly, while release of the second CO molecule proceeds more slowly. In vitro studies using two cell lines A431 (human squamous carcinoma) and HEK293 (human embryonic kidney cells) have been carried out in order characterise the anti-proliferative and anti-apoptotic activities. The BODIPY-labelled compound allows for monitoring the cellular uptake, showing fast internalisation kinetics and accumulation at the endoplasmic reticulum and mitochondria.
- Published
- 2020
3. Intracellular Fate of Polymer Therapeutics Investigated by Fluorescence Lifetime Imaging and Fluorescence Pattern Analysis
- Author
-
PANEK, J., primary, KOZIOLOVA, E., additional, STEPANEK, P., additional, ETRYCH, T., additional, and JANOUSKOVA, O., additional
- Published
- 2016
- Full Text
- View/download PDF
4. Nanotherapeutics With Anthracyclines: Methods of Determination and Quantification of Anthracyclines in Biological Samples
- Author
-
KOZIOLOVA, E., primary, JANOUSKOVA, O., additional, CHYTIL, P., additional, STUDENOVSKY, M., additional, KOSTKA, L., additional, and ETRYCH, T., additional
- Published
- 2015
- Full Text
- View/download PDF
5. Nanoparticles embedded in a sponge of polydimethylsiloxane by laser ablation in liquid
- Author
-
Cutroneo Mariapompea, Havranek Vladimir, Torrisi Lorenzo, Silipigni Letteria, Kovacik Lubomir, Malinsky Petr, Flaks Josef, Slepicka Petr, Fajstavr Dominik, Janoušková Olga, Zbořilová Daniela, and Mackova Anna
- Subjects
Physics ,QC1-999 - Abstract
This work describes the preparation of polydimethylsiloxane (PDMS) sponge with pore sizes of about 50 and 900 µm. The sponges synthetized by the sugar template process were embedded with graphene oxide (GO) and gold nanoparticles (AuNPs) previously produced by laser ablation in liquid. The suspension containing graphene oxide and gold nanoparticles were optically characterized by UV-ViS spectroscopy. The dispersion of the nanoparticles in the PDMS sponges was observed by the Scanning Electron Microscopy (SEM). The biocompatibility of virgin PDMS, PDMS filled with graphene oxide, and with graphene oxide and gold nanoparticles was studied for different types of cell cultures. This study has allowed us to confirm that the PDMS sponge is a good matrix for embedding AuNPs and has highlighted as the presence of GO hinders the aggregation of AuNPs avoiding the use of surfactant and allowing their use in biological applications.
- Published
- 2022
- Full Text
- View/download PDF
6. Comparison of two isolation methods of tobacco-derived extracellular vesicles, their characterization and uptake by plant and rat cells.
- Author
-
Kocholata M, Prusova M, Auer Malinska H, Maly J, and Janouskova O
- Subjects
- Humans, Rats, Animals, Nicotiana, Plants metabolism, Biological Transport, Mammals, Extracellular Vesicles metabolism, Mesenchymal Stem Cells
- Abstract
Plant extracellular vesicles (pEVs) derived from numerous edible sources gain a lot of attention in recent years, mainly due to the potential to efficiently carry bioactive molecules into mammalian cells. In the present study, we focus on isolation of PDNVs (plant-derived nanovesicles) and pEVs from callus culture and from BY-2 culture of Nicotiana tabacum (tobacco). Tobacco was selected as a source of plant vesicles, as it is commonly used by human, moreover it is a model organism with established techniques for cultivation of explant cultures in vitro. Explant cultures are suitable for the isolation of pEVs in large quantities, due to their fast growth in sterile conditions. As the efficiency of isolation methods varies, we were comparing two methods of isolation. We evaluated biophysical and biochemical properties of plant vesicles, as well as differences between isolates. We encountered difficulties in the form of vesicles aggregation, which is often described in publications focused on mammalian nanovesicles. In an effort to prevent vesicle aggregation, we used trehalose in different stages of isolation. We show tobacco-derived vesicles successfully enter tobacco and mesenchymal cell lines. We observed that tobacco-nanovesicles isolated by different methods incorporated fluorescent dye with different efficiency. The results of our study show tobacco-derived vesicles isolated by various isolation methods are able to enter plant, as well as mammalian cells., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
7. Conventional and Nonconventional Sources of Exosomes-Isolation Methods and Influence on Their Downstream Biomedical Application.
- Author
-
Janouskova O, Herma R, Semeradtova A, Poustka D, Liegertova M, Hana Auer M, and Maly J
- Abstract
Despite extensive study of extracellular vesicles (EVs), specifically exosomes (EXs) as biomarkers, important modulators of physiological or pathological processes, or therapeutic agents, relatively little is known about nonconventional sources of EXs, such as invertebrate or plant EXs, and their uses. Likewise, there is no clear information on the overview of storage conditions and currently used isolation methods, including new ones, such as microfluidics, which fundamentally affect the characterization of EXs and their other biomedical applications. The purpose of this review is to briefly summarize conventional and nonconventional sources of EXs, storage conditions and typical isolation methods, widely used kits and new "smart" technologies with emphasis on the influence of isolation techniques on EX content, protein detection, RNA, mRNA and others. At the same time, attention is paid to a brief overview of the direction of biomedical application of EXs, especially in diagnostics, therapy, senescence and aging and, with regard to the current situation, in issues related to Covid-19., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Olga, Regina, Alena, David, Michaela, Malinska and Jan.)
- Published
- 2022
- Full Text
- View/download PDF
8. The Effect of iPS-Derived Neural Progenitors Seeded on Laminin-Coated pHEMA-MOETACl Hydrogel with Dual Porosity in a Rat Model of Chronic Spinal Cord Injury.
- Author
-
Ruzicka J, Romanyuk N, Jirakova K, Hejcl A, Janouskova O, Machova LU, Bochin M, Pradny M, Vargova L, and Jendelova P
- Subjects
- Animals, Cell Differentiation, Chronic Disease, Hydrogels, Male, Rats, Induced Pluripotent Stem Cells metabolism, Neural Stem Cells transplantation, Spinal Cord Injuries therapy
- Abstract
Spinal cord injury (SCI), is a devastating condition leading to the loss of locomotor and sensory function below the injured segment. Despite some progress in acute SCI treatment using stem cells and biomaterials, chronic SCI remains to be addressed. We have assessed the use of laminin-coated hydrogel with dual porosity, seeded with induced pluripotent stem cell-derived neural progenitors (iPSC-NPs), in a rat model of chronic SCI. iPSC-NPs cultured for 3 weeks in hydrogel in vitro were positive for nestin, glial fibrillary acidic protein (GFAP) and microtubule-associated protein 2 (MAP2). These cell-polymer constructs were implanted into a balloon compression lesion, 5 weeks after lesion induction. Animals were behaviorally tested, and spinal cord tissue was immunohistochemically analyzed 28 weeks after SCI. The implanted iPSC-NPs survived in the scaffold for the entire experimental period. Host axons, astrocytes and blood vessels grew into the implant and an increased sprouting of host TH
+ fibers was observed in the lesion vicinity. The implantation of iPSC-NP-LHM cell-polymer construct into the chronic SCI led to the integration of material into the injured spinal cord, reduced cavitation and supported the iPSC-NPs survival, but did not result in a statistically significant improvement of locomotor recovery.- Published
- 2019
- Full Text
- View/download PDF
9. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
- Author
-
Sedlacek O, Monnery BD, Mattova J, Kucka J, Panek J, Janouskova O, Hocherl A, Verbraeken B, Vergaelen M, Zadinova M, Hoogenboom R, and Hruby M
- Subjects
- Animals, Cell Line, Tumor, Female, Flow Cytometry, HeLa Cells, Humans, MCF-7 Cells, Mice, Mice, Inbred C57BL, Microscopy, Confocal, Acrylamides chemistry, Doxorubicin chemistry, Doxorubicin therapeutic use, Drug Carriers chemistry, Nanomedicine methods, Polyamines chemistry, Polymers chemistry
- Abstract
We designed and synthesized a new delivery system for the anticancer drug doxorubicin based on a biocompatible hydrophilic poly(2-ethyl-2-oxazoline) (PEtOx) carrier with linear architecture and narrow molar mass distribution. The drug is connected to the polymer backbone via an acid-sensitive hydrazone linker, which allows its triggered release in the tumor. The in vitro studies demonstrate successful cellular uptake of conjugates followed by release of the cytostatic cargo. In vivo experiments in EL4 lymphoma bearing mice revealed prolonged blood circulation, increased tumor accumulation and enhanced antitumor efficacy of the PEtOx conjugate having higher molecular weight (40 kDa) compared to the lower molecular weight (20 kDa) polymer. Finally, the in vitro and in vivo anti-cancer properties of the prepared PEtOx conjugates were critically compared with those of the analogous system based on the well-established PHPMA carrier. Despite the relatively slower intracellular uptake of PEtOx conjugates, resulting also in their lower cytotoxicity, there are no substantial differences in in vivo biodistribution and anti-cancer efficacy of both classes of polymer-Dox conjugates. Considering the synthetic advantages of poly(2-alkyl-2-oxazoline)s, the presented study demonstrates their potential as a versatile alternative to well-known PEO- or PHPMA-based materials for construction of drug delivery systems., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
10. Detection of the GPI-anchorless prion protein fragment PrP226* in human brain.
- Author
-
Dvorakova E, Vranac T, Janouskova O, Černilec M, Koren S, Lukan A, Nováková J, Matej R, Holada K, and Čurin Šerbec V
- Subjects
- 14-3-3 Proteins metabolism, Brain drug effects, Endopeptidase K pharmacology, Enzyme-Linked Immunosorbent Assay, Female, Glycosylphosphatidylinositols metabolism, Humans, Male, PrPSc Proteins drug effects, Statistics as Topic, Temperature, Brain metabolism, Creutzfeldt-Jakob Syndrome pathology, PrPSc Proteins metabolism
- Abstract
Background: The accumulation of the misfolded forms of cellular prion protein, i.e. prions (PrPSc), in the brain is one of the crucial characteristics of fatal neurodegenerative disorders, called transmissible spongiform encephalopathies (TSEs). Cellular prion protein is normally linked to the cell surface by the glycosylphosphatidylinositol (GPI) anchor. There is accumulating evidence that the GPI-anchorless prion protein may act as an accelerator of formation and propagation of prions. In the TSE affected human brain we have previously discovered a novel GPI-anchorless prion protein fragment, named PrP226*, which ends with the tyrosine 226. This fragment can be labeled specifically by the monoclonal antibody V5B2., Methods: We developed a DELFIA based assay for quick and sensitive detection of the PrP226* fragment in human brain tissue homogenates. By calculating the ratio between the signals of native (N) and denatured (D) samples applied to the assay we were able to observe significant difference between 24 TSE affected brains and 10 control brains. The presence of PrP226* in brain tissue was confirmed by western blot., Results: Our results demonstrate that PrP226* is present in small quantities in healthy human brain, whereas in degenerated brain it accumulates in prion aggregates, proportionally to PrPSc. Samples with high D/N ratio generally comprised more proteinase K resistant PrP, while no correlation was found between the quantity of PrP226* and standard classification of Creutzfeldt-Jakob disease (CJD)., Conclusions: In the present study we show that the PrP226* fragment accumulates in prion aggregates and after being released from them by a denaturation procedure, could serve as a proteinase K digestion independent biomarker for human TSEs. The PrP226* assay described in this paper offers a tool to follow and study this unique anchorless PrP fragment in various parts of human brain and possibly also in other tissues and body fluids.
- Published
- 2013
- Full Text
- View/download PDF
11. Photodynamic inactivation of prions by disulfonated hydroxyaluminium phthalocyanine.
- Author
-
Janouskova O, Rakusan J, Karaskova M, and Holada K
- Subjects
- Animals, Brain, Cell Line, Dose-Response Relationship, Drug, Indoles chemistry, Isoindoles, Mice, Molecular Structure, Neurons, Pressure, Sulfonic Acids chemistry, Temperature, Time Factors, Indoles pharmacology, Photochemotherapy methods, Prions drug effects, Sulfonic Acids pharmacology
- Abstract
Sulfonated phthalocyanines (Pcs) are cyclic tetrapyrroles that constitute a group of photosensitizers. In the presence of visible light and diatomic oxygen, Pcs produce singlet oxygen and other reactive oxygen species that have known degradation effects on lipids, proteins and/or nucleic acids. Pcs have been used successfully in the treatment of bacterial, yeast and fungal infections, but their use in the photodynamic inactivation of prions has never been reported. Here, we evaluated the photodynamic activity of the disodium salt of disulfonated hydroxyaluminium phthalocyanine (PcDS) against mouse-adapted scrapie RML prions in vitro. PcDS treatment of RML brain homogenate resulted in a time- and dose-dependent inactivation of prions. The photodynamic potential of Pcs offers a new way to inactivate prions using biodegradable compounds at room temperature and normal pressure, which could be useful for treating thermolabile materials and liquids.
- Published
- 2012
- Full Text
- View/download PDF
12. Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice.
- Author
-
Matej R, Olejar T, Janouskova O, and Holada K
- Subjects
- Animals, Female, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Prions genetics, Prions metabolism, Receptor, PAR-2 deficiency, Scrapie genetics, Scrapie metabolism, Gene Deletion, Receptor, PAR-2 genetics, Scrapie enzymology, Scrapie mortality
- Abstract
Proteinase-activated receptor 2 (PAR2) has recently been identified to be a possible modulator of neurodegeneration. To investigate whether PAR2 plays a role in prion infection, we inoculated PAR2-deficient (PAR2(-/-)) and wild-type (WT) mice intracerebrally with the Rocky Mountain Laboratory strain of scrapie. PAR2(-/-) mice demonstrated a delayed onset of clinical symptoms, including weight loss, and demonstrated moderate but highly significant prolongation of survival over WT controls. Concomitantly, no apparent differences in brain pathology, infectivity or features of brain prion protein between deceased WT and PAR2(-/-) mice were found. Our study suggests that PAR2 deletion modulates dynamics of the disease without gross perturbation of its pathogenesis.
- Published
- 2012
- Full Text
- View/download PDF
13. Delivery of recombinant adeno-associated virus by jet injection.
- Author
-
Janouskova O, Nellessen T, Stokrova J, Jinoch P, and Smahel M
- Subjects
- Animals, Cell Line, DNA, Recombinant genetics, Green Fluorescent Proteins, Humans, Injections, Jet, Interleukin-2 genetics, Interleukin-2 metabolism, Luminescent Proteins analysis, Luminescent Proteins genetics, Mice, Neoplasms genetics, Neoplasms metabolism, Transgenes genetics, beta-Galactosidase genetics, beta-Galactosidase metabolism, Dependovirus genetics, Gene Transfer Techniques
- Abstract
The jet-injection technology was used for delivery of recombinant adeno-associated virus (rAAV). Although AAV-based vectors are an attractive tool in gene therapy, some methodological and technical problems of their targeted delivery remain to be solved. We tried to address some of these cell-targeting problems by using a new low-volume needleless injection device the Swiss Injector. First we tested, by electron microscopy, whether jet-injection would have any detrimental effect on rAAV particle integrity. Second, we compared transgene expression after infection of 293T cells with fired or control (non-fired) rAAV that expressed the green fluorescent protein (GFP), beta-galactosidase (beta-gal), the B7.1 molecule, and interleukin 2 (IL2). Third, an rAAV carrying the genes coding for beta-gal was jet-injected into mouse subcutaneous (s.c.) tumours. The staining of tumour cryosections revealed beta-gal expression 72 h after the delivery. Our study demonstrated the applicability of the Swiss Injector for the delivery of rAAV into tumour tissue without either vector particle integrity or the level of expression of the transgenes, as tested in vitro, being affected. The jet-injection technology could improve the distribution of vector particles in the tumour mass without leakage of liquid from the injection site.
- Published
- 2003
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.